Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

KELLY GEORGE MCCAUL

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1295701522
CMS profile
194337
Location
SIOUX FALLS, SD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$141,956.74

99 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
Karyopharm Therapeutics Inc. $50,190.60 26
Incyte Corporation $27,627.64 17
Celgene Corporation $19,186.71 17
Takeda Pharmaceuticals U.S.A., Inc. $14,790.23 9
AstraZeneca Pharmaceuticals LP $7,832.50 5
Kite Pharma, Inc. $7,804.74 11
Amgen Inc. $5,750.00 3
Seagen Inc. $5,241.93 5
Janssen Biotech, Inc. $1,513.39 3
Verastem, Inc. $1,320.00 1
Pharmacyclics LLC, An AbbVie Company $699.00 2

Page 2 of 2; records 51–99 of 99 matching records. This page contains 49 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

KELLY GEORGE MCCAUL

NPI 1295701522 · CMS profile ID 194337

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

SIOUX FALLS, SD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–99 of 99 matching records. This page contains 49 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1295701522?year=2020&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
KELLY GEORGE MCCAUL, NPI 1295701522, CMS profile ID 194337. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–99 of 99 matching records. This page contains 49 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1295701522?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). KELLY GEORGE MCCAUL, NPI 1295701522, CMS profile ID 194337. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–99 of 99 matching records. This page contains 49 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1295701522?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
KELLY GEORGE MCCAUL, NPI 1295701522, CMS profile ID 194337, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–99 of 99 matching records. This page contains 49 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1295701522?year=2020&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

99 matching records · $141,956.74 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 99 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–99 of 99.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Pharmacyclics LLC, An AbbVie Company $99.0006/23/2020 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725664140 CMS
Janssen Biotech, Inc. $500.0006/15/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 719246011 CMS
Seagen Inc. $650.0006/10/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 732446335 CMS
Celgene Corporation $1,428.0806/01/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728003589 CMS
Celgene Corporation $2,073.6905/27/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728003587 CMS
Celgene Corporation $669.4005/27/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728003617 CMS
Celgene Corporation $25.0005/27/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728003621 CMS
Pharmacyclics LLC, An AbbVie Company $600.0005/20/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 725667907 CMS
Seagen Inc. $865.0005/18/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 732446155 CMS
AstraZeneca Pharmaceuticals LP $2,220.0004/19/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736115167 CMS
Celgene Corporation $1,130.0004/16/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728003595 CMS
Verastem, Inc. $1,320.0004/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 750486789 CMS
Incyte Corporation $463.4003/26/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 745815203 CMS
Kite Pharma, Inc. $4,600.0003/17/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 731512817 CMS
Kite Pharma, Inc. $517.5503/17/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 731512881 CMS
Kite Pharma, Inc. $63.9803/17/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 731512885 CMS
Incyte Corporation $2,460.0003/16/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 745814985 CMS
Celgene Corporation $1,130.0003/13/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728003597 CMS
Celgene Corporation $607.3003/12/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728003585 CMS
Celgene Corporation $798.0003/12/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728003591 CMS
Celgene Corporation $306.2403/12/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728003593 CMS
Takeda Pharmaceuticals U.S.A., Inc. $6,600.0002/29/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753941324 CMS
Takeda Pharmaceuticals U.S.A., Inc. $149.3802/29/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753941326 CMS
Takeda Pharmaceuticals U.S.A., Inc. $320.1602/29/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753941328 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,102.4002/29/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753941330 CMS
Takeda Pharmaceuticals U.S.A., Inc. $49.2002/29/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 753941332 CMS
Karyopharm Therapeutics Inc. $700.0002/20/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751736133 CMS
Karyopharm Therapeutics Inc. $99.4702/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751736135 CMS
Karyopharm Therapeutics Inc. $1,750.0002/20/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751736138 CMS
Kite Pharma, Inc. $35.1302/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 731513179 CMS
Kite Pharma, Inc. $50.0002/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 731513183 CMS
Kite Pharma, Inc. $12.5002/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 731513187 CMS
Kite Pharma, Inc. $12.5002/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 731513191 CMS
Kite Pharma, Inc. $487.1702/14/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 731512877 CMS
Kite Pharma, Inc. $1,216.1902/14/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 731513045 CMS
Kite Pharma, Inc. $209.7202/14/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 731513049 CMS
Takeda Pharmaceuticals U.S.A., Inc. $610.5002/05/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747331107 CMS
Karyopharm Therapeutics Inc. $1,750.0002/04/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751736119 CMS
Karyopharm Therapeutics Inc. $950.0002/04/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751736123 CMS
Karyopharm Therapeutics Inc. $118.0402/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751736127 CMS
Karyopharm Therapeutics Inc. $2,100.0002/04/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751736129 CMS
AstraZeneca Pharmaceuticals LP $2,800.0001/28/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736053353 CMS
Takeda Pharmaceuticals U.S.A., Inc. $4,620.0001/28/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747331100 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.5901/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747331103 CMS
AstraZeneca Pharmaceuticals LP $37.5001/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736203917 CMS
Karyopharm Therapeutics Inc. $1,400.0001/16/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751736141 CMS
Incyte Corporation $4,920.0001/14/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 745814971 CMS
Incyte Corporation $1,267.4601/07/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 745815107 CMS
Incyte Corporation $100.0001/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 745815111 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $253,460.09 219
PY2020 $141,956.74 99
PY2021 $204,771.35 167
PY2022 $251,779.21 196
PY2023 $179,333.96 180
PY2024 $114,551.44 114
PY2025 $91,414.09 99

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $17,061.66 2
PY2022 Principal investigator $4,880.00 5
PY2021 Principal investigator $12,693.30 2
PY2020 Principal investigator $47,256.65 21
PY2019 Recipient $935.00 1
PY2019 Principal investigator $188,118.29 49

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

2 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Celgene Corporation $15,500.00 06/24/2024 Non-covered Recipient Entity
University Health System Inc Attn Lawanda Duenckel
TRANSFORM CLL (PMR LisoCel vs Investigator Choice) - A Study to Evaluate the Efficacy and Safety of Lisocabtagene Maraleucel Monotherapy Compared to Investigator s Choice Options (Idelalisib + Rituximab or Bendamustine + Rituximab) in Adult Participants w No dispute reported 06/30/2026 1155550181
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $1,561.66 03/26/2024 Covered Recipient Teaching Hospital
University Of Tennessee Medical Cent
TRANSFORM CLL (PMR LisoCel vs Investigator Choice) - A Study to Evaluate the Efficacy and Safety of Lisocabtagene Maraleucel Monotherapy Compared to Investigator s Choice Options (Idelalisib + Rituximab or Bendamustine + Rituximab) in Adult Participants w No dispute reported 06/30/2026 1123473301